Home
      Diagnosis
      Treatment
      Pathology
      Variants
      CIDP info
      GBS
      IVIG
      Diet
      About Us
       E-Book
      Email Web Weaver
    Autoimmune diseases
        News
        Links
 

 

 

 

PTSD

MORGELLONS AND NANOMACHINES

Morgellons - New Disease, or
Man-Made Weapon of Terror?

 FMS CFS   Myofacial   Fibromyalgia

 IVIg

Diseases

PRA

Celiac disease Info

More on Celiac disease

Anemia and celiac disease

Home for autoimmune disorders, information about autoimmune diseases

Lahore Sex clinic

lAHORE CLINIC

Everything about IVIg, Home to IVIg

Home to autoimmune diseases, causes, treatment, cure, e-book

Home to autoimmune disorders , treatment , causes, information

Fatty acids in autoimmune diseases

AUTOIMMUNE EPIDEMIC

Magnetic deficiency syndrome

Small fiber neuropathy

Biophosphates memantine HCl and muscular pains

Bio of HAKIM ABU AL

Pernicious anemia

Chemicals in soap danger

 

 

 

 

 

 
 
 

                                                   Prostate cancer

     

                       

Many diseases are autoimmune and easily and permanently treatable please read our e-book for permanent treatments.

               

                          Welcome to the CIDP  International organization .         
                               

Can Selenium Stop Prostate Cancer?

Prostate cancer is the most commonly diagnosed cancer among American men, according to the Washington, D.C.-based National Cancer Institute (NCI). However, the bulk of these cancers remain latent, and only a small number progress to cause illness or death. In 1997, NCI estimated 210,000 new cases were diagnosed and 42,000 men died as a result of their cancer. A recent study suggests eating foods rich in the trace mineral selenium—organ meats, seafood and whole grains—may help men reduce their risk of advanced prostate cancer.1

To determine this, researchers from Harvard University studied 33,737 male health professionals, all of whom provided toenail clippings that were stored for later analysis. Because the selenium content of toenails is a good indicator of selenium status, the stored material provided an opportunity to match selenium status before diagnosis with a later occurrence of prostate cancer. The study began in 1987 as part of a prostate cancer study in which selenium was not supplemented.

Participants filled out questionnaires during the course of the study, and all new cases of prostate cancer were recorded. From 1989 through 1994, the group reported 181 new cases of advanced prostate cancer. Each case was matched with a control subject (one who did not have prostate cancer) of the same age and smoking status. The toenail samples of both the cases and controls were analyzed for selenium.

Results showed the mean toenail selenium level was significantly higher in control subjects than in cancer subjects. When subjects in the highest 20 percent for selenium status were compared with those in the lowest 20 percent, those with the highest selenium status were half as likely to get prostate cancer as those with the lowest levels.

While this study shows an association between low selenium levels and occurrence of prostate cancer, it does not show that the relationship is causal. Additional well-planned, controlled studies are needed to show whether raising selenium levels can protect against this disease. However, this report adds another strong piece of supportive evidence.

S.B.

References

1. Yoshizawa K, etal. Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer. J Nat Canc Inst 1998 Aug 19;90(16):1219-24.


 

 

 

 

I

www.cidpusa.org  www.cidpusa.org/P/ivig.htm  http://www.cidpusa.org/disease.html http://www.cidpusa.org/Lahore.html